Clinical trial
Treatment of Wegener's Granulomatosis With Cyclophosphamide
NCT00001155 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Wegener's Granulomatosis With Cyclophosphamide
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 1976
- Completion date
- February 28, 2002
- Enrollment
- 200
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vasculitis, wegener's granulomatosis